Periocular routes for retinal drug delivery (Q36316631)

13 August 2017

1 reference

title

Periocular routes for retinal drug delivery (English)

1 reference

13 August 2017

1 reference

Swita Raghava

1 reference

13 August 2017

Makena Hammond

series ordinal

1 reference

13 August 2017

Uday B Kompella

series ordinal

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

Expert Opinion on Drug Delivery

13 August 2017

published in

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

99-114

1 reference

Retinal venous oxygen saturation and cardiac output during controlled hemorrhage and resuscitation

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Clinically important ocular reactions to systemic drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Drug delivery to the posterior segment of the eye: some insights on the penetration pathways after subconjunctival injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Aminoglycoside toxicity--a survey of retinal specialists. Implications for ocular use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

New developments in sustained release drug delivery for the treatment of intraocular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Evaluation of the Retinal Toxicity and Pharmacokinetics of Dexamethasone After Intravitreal Injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Sub-Tenon's administration of local anaesthetic: a review of the technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Guidance of retrobulbar injection with real-time tomographic reflection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Drug delivery to the posterior segment from drops

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Iganidipine, a new water-soluble Ca2+ antagonist: ocular and periocular penetration after instillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Inflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenac

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Topical nepafenac inhibits ocular neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Pharmacokinetics of insulin uptake by ocular tissues and the role of cerebrospinal fluid in optic nerve insulin accumulation following topical insulin application

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Bioavailability of nafarelin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Kinetics of macromolecules injected into the subretinal space

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Diffusion of immunoglobulins into rabbit cornea after subconjunctival injection: experimental demonstration and mathematical model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Periocular gene transfer of sFlt-1 suppresses ocular neovascularization and vascular endothelial growth factor-induced breakdown of the blood-retinal barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Transscleral drug delivery for posterior segment disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Permeability of Human Cornea and Sclera to Sulfonamide Carbonic Anhydrase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

In vitro human scleral permeability of fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein and rhodamine 6G and the use of a coated coil as a new drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Scleral permeability of a small, single-stranded oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Local pressure effects on vitreous kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

Posterior sub-Tenon's steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.99

21 January 2018

Identifiers

DOI

10.1517/17425247.1.1.99

1 reference

13 August 2017

1 reference